Bracco Imaging and NYU Langone Health Form Multi-Year Research Alliance in Medical Imaging
Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in medical imaging through a multi-year Master Research Agreement, announced in a press release.
The collaboration will focus on developing and optimizing technologies in Magnetic Resonance Imaging (MRI), Photon-Counting Computed Tomography (PCCT), targeted ultrasound, and artificial intelligence-enabled PET/CT and MRI image analysis. The goal is to enhance diagnostic performance, streamline clinical workflows, and improve patient management.
Joint research activities will combine NYU Langone Health’s clinical and academic expertise with Bracco Imaging’s experience in contrast imaging and diagnostic solutions. The agreement is structured to strengthen ties between research and clinical practice, supporting the translation of scientific findings into healthcare applications.
According to Bracco Imaging’s CEO Fulvio Renoldi Bracco and NYU Langone’s Chair of Radiology Michael P. Recht, the partnership reflects a shared effort to drive progress in precision medicine and diagnostic accuracy through advanced imaging and artificial intelligence.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Sep 20 Litera Brings Foundation Firm AI Search to ChatGPT Enterprise Sep 19 Collinson Funds Priority Pass AI and App Expansion Through £500 Million Program Sep 19 Disney Names Former Character.ai CEO as Its First CTO Sep 19 Anthropic Picks Accenture for AI Safety Testing Sep 19 Huawei Unveils Immersive Telepresence SystemMore from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Colorado Imaging Associates and TRA Form Affiliated Radiology
NYU Langone AI Uses Multiple 3D Mammograms to Predict Breast Cancer Risk
HiRO and Differentia Biotech Sign MOU for AI Clinical Trial Simulation
Linearis Joins Two Canadian AI Health Data Projects
nference and Rush Plan Clinical Analytics Platform for Research
Daily AI Brief: the AI news that matters, in your inbox.